RU2018113459A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2018113459A3 RU2018113459A3 RU2018113459A RU2018113459A RU2018113459A3 RU 2018113459 A3 RU2018113459 A3 RU 2018113459A3 RU 2018113459 A RU2018113459 A RU 2018113459A RU 2018113459 A RU2018113459 A RU 2018113459A RU 2018113459 A3 RU2018113459 A3 RU 2018113459A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/541—Organic ions forming an ion pair complex with the pharmacologically or therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6907—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a microemulsion, nanoemulsion or micelle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Rheumatology (AREA)
- Nanotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20150130587 | 2015-09-15 | ||
| KR10-2015-0130587 | 2015-09-15 | ||
| KR1020160117053A KR101828877B1 (ko) | 2015-09-15 | 2016-09-12 | 음이온성 약물 함유 약제학적 조성물 및 그 제조방법 |
| PCT/KR2016/010269 WO2017048018A1 (ko) | 2015-09-15 | 2016-09-12 | 음이온성 약물 함유 약제학적 조성물 및 그 제조방법 |
| KR10-2016-0117053 | 2016-09-12 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2018113459A3 true RU2018113459A3 (ru) | 2019-10-18 |
| RU2018113459A RU2018113459A (ru) | 2019-10-18 |
| RU2721558C2 RU2721558C2 (ru) | 2020-05-20 |
Family
ID=58496160
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2018113459A RU2721558C2 (ru) | 2015-09-15 | 2016-09-12 | Фармацевтическая композиция, содержащая анионное лекарственное средство, и способ ее получения |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US11253598B2 (ru) |
| EP (1) | EP3357491B1 (ru) |
| JP (1) | JP6638072B2 (ru) |
| KR (2) | KR101828877B1 (ru) |
| CN (1) | CN108024960B (ru) |
| AU (1) | AU2016324450B2 (ru) |
| CA (1) | CA2998092C (ru) |
| DK (1) | DK3357491T3 (ru) |
| ES (1) | ES2883290T3 (ru) |
| HK (1) | HK1251464A1 (ru) |
| IL (1) | IL257937B (ru) |
| MX (1) | MX2018003096A (ru) |
| PT (1) | PT3357491T (ru) |
| RU (1) | RU2721558C2 (ru) |
| SG (1) | SG11201802073YA (ru) |
| ZA (1) | ZA201802303B (ru) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180344638A1 (en) * | 2015-12-18 | 2018-12-06 | Samyang Biopharmaceuticals Corporation | Method for preparing polymeric micelle containing anionic drug |
| KR102175069B1 (ko) * | 2017-11-10 | 2020-11-05 | 주식회사 삼양바이오팜 | 음이온성 약물 전달용 지질 나노입자의 동결건조 조성물 및 방법 |
| KR102259513B1 (ko) * | 2017-11-16 | 2021-06-02 | 주식회사 삼양홀딩스 | 음이온성 약물 함유 약제학적 조성물의 동결건조 조성물 및 방법 |
| KR20190127277A (ko) * | 2018-05-04 | 2019-11-13 | 주식회사 삼양바이오팜 | mRNA 전달용 고분자 나노입자 조성물 및 그 제조방법 |
| AU2019317180B2 (en) * | 2018-08-07 | 2022-08-11 | Samyang Holdings Corporation | Polymer nanoparticle composition for delivering virus, and preparation method therefor |
| CN109136271B (zh) * | 2018-09-20 | 2021-07-20 | 西北工业大学 | 阳离子聚乙烯胺线形高分子作为转基因载体的应用 |
| JP2023500921A (ja) | 2019-11-07 | 2023-01-11 | サムヤン ホールディングス コーポレイション | 免疫誘導用ポリマーナノ粒子組成物及びその製造方法 |
| EP4062908A4 (en) * | 2019-11-22 | 2024-01-24 | Samyang Holdings Corporation | KIT FOR PREPARING A NANOPARTICLE COMPOSITION FOR DRUG DELIVERY |
| AU2020407348A1 (en) * | 2019-12-20 | 2022-07-14 | Samyang Holdings Corporation | Kit for preparing nanoparticle composition for drug delivery, comprising polylactic acid salt |
| BR112022020991A2 (pt) * | 2020-08-31 | 2023-03-07 | Vaim Co Ltd | Dispersão de polímero biodegradável, composição compreendendo a mesma e sistema de melhoria da pele |
| CN117241791A (zh) * | 2021-04-30 | 2023-12-15 | 三养控股公司 | 包含不含两亲聚合物的纳米颗粒的用于药物递送的组合物 |
| GB202108444D0 (en) * | 2021-06-14 | 2021-07-28 | Imperial College Innovations Ltd | Sub-micron particle |
| CN114569577B (zh) * | 2022-03-07 | 2023-04-11 | 晟迪生物医药(苏州)有限公司 | 一种聚合物包衣纳米粒及其制备方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR0180334B1 (ko) | 1995-09-21 | 1999-03-20 | 김윤 | 블럭 공중합체 미셀을 이용한 약물전달체 및 이에 약물을 봉입하는 방법 |
| US6458382B1 (en) | 1999-11-12 | 2002-10-01 | Mirus Corporation | Nucleic acid transfer complexes |
| ATE450621T2 (de) | 2000-03-30 | 2009-12-15 | Whitehead Biomedical Inst | Mediatoren von rns-interferenz, die rns- sequenzspezifisch sind |
| CA2472170A1 (en) | 2001-12-28 | 2003-07-24 | Supratek Pharma Inc. | Pharmaceutical compositions comprising polyanionic polymers and amphiphilic block copolymers and methods of use thereof to improve gene expression |
| AU2003288902A1 (en) * | 2002-09-06 | 2004-04-08 | Genteric, Inc. | Microcapsules and methods of use |
| WO2005107813A1 (en) | 2004-05-06 | 2005-11-17 | Samyang Corporation | Delivery system for bioactive agents on the basis of a polymeric drug carrier comprising an amphiphilic block polymer and a polylacticacid derivative |
| KR100949791B1 (ko) | 2007-12-18 | 2010-03-30 | 이동기 | 오프-타겟 효과를 최소화하고 ＲＮＡｉ 기구를 포화시키지않는 신규한 ｓｉＲＮＡ 구조 및 그 용도 |
| US20090312402A1 (en) * | 2008-05-20 | 2009-12-17 | Contag Christopher H | Encapsulated nanoparticles for drug delivery |
| CA2732412C (en) * | 2008-07-30 | 2014-12-09 | Lei Yu | Retinoid-targeted drug carriers |
| EP2376062B1 (en) | 2008-12-26 | 2017-04-26 | Samyang Biopharmaceuticals Corporation | Preparation method of polymeric micellar nanoparticles composition containing a poorly water-soluble drug |
| US20110268772A1 (en) * | 2008-12-26 | 2011-11-03 | Samyang Corporation | Pharmaceutical composition containing an anionic drug and a production method thereof |
| KR101296326B1 (ko) * | 2009-12-30 | 2013-08-14 | 주식회사 삼양바이오팜 | 폴리락트산을 포함하는 음이온성 약물 전달용 조성물 및 그 제조 방법 |
| US9314529B2 (en) | 2010-07-09 | 2016-04-19 | The University Of Tokyo | Nucleic acid delivery composition and carrier composition, pharmaceutical composition using the same, and method for nucleic acid delivery |
| EP2658577A4 (en) | 2010-12-30 | 2016-08-24 | Samyang Biopharmaceuticals | CARRIER FOR NEGATIVELY LOADED MEDICAMENTS WITH A CATIONIC LIPID AND METHOD FOR THE PRODUCTION THEREOF |
| KR101480055B1 (ko) * | 2012-04-04 | 2015-01-09 | 주식회사 삼양바이오팜 | 음이온성 약물 전달체의 제조 방법 |
| KR102109188B1 (ko) * | 2013-04-01 | 2020-05-11 | 삼성전자주식회사 | 양이온성 지질을 포함하는 온도민감성 리포좀 및 그의 용도 |
| WO2014169007A2 (en) | 2013-04-09 | 2014-10-16 | University Of Georgia Research Foundation Inc. | Combination therapeutic nanoparticles |
-
2016
- 2016-09-12 CN CN201680053810.0A patent/CN108024960B/zh active Active
- 2016-09-12 SG SG11201802073YA patent/SG11201802073YA/en unknown
- 2016-09-12 ES ES16846839T patent/ES2883290T3/es active Active
- 2016-09-12 RU RU2018113459A patent/RU2721558C2/ru active
- 2016-09-12 PT PT168468395T patent/PT3357491T/pt unknown
- 2016-09-12 MX MX2018003096A patent/MX2018003096A/es unknown
- 2016-09-12 US US15/759,943 patent/US11253598B2/en active Active
- 2016-09-12 JP JP2018533597A patent/JP6638072B2/ja active Active
- 2016-09-12 AU AU2016324450A patent/AU2016324450B2/en active Active
- 2016-09-12 DK DK16846839.5T patent/DK3357491T3/da active
- 2016-09-12 KR KR1020160117053A patent/KR101828877B1/ko active IP Right Grant
- 2016-09-12 EP EP16846839.5A patent/EP3357491B1/en active Active
- 2016-09-12 CA CA2998092A patent/CA2998092C/en active Active
-
2018
- 2018-01-16 KR KR1020180005600A patent/KR101948839B1/ko active IP Right Grant
- 2018-03-07 IL IL257937A patent/IL257937B/en active IP Right Grant
- 2018-04-09 ZA ZA2018/02303A patent/ZA201802303B/en unknown
- 2018-08-24 HK HK18110936.6A patent/HK1251464A1/zh unknown
-
2022
- 2022-01-10 US US17/572,195 patent/US20220125929A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DK3357491T3 (da) | 2021-08-02 |
| IL257937B (en) | 2020-10-29 |
| MX2018003096A (es) | 2018-05-11 |
| PT3357491T (pt) | 2021-08-02 |
| CA2998092A1 (en) | 2017-03-23 |
| EP3357491B1 (en) | 2021-06-02 |
| SG11201802073YA (en) | 2018-04-27 |
| JP6638072B2 (ja) | 2020-01-29 |
| CN108024960A (zh) | 2018-05-11 |
| RU2721558C2 (ru) | 2020-05-20 |
| ES2883290T3 (es) | 2021-12-07 |
| KR20180008854A (ko) | 2018-01-24 |
| JP2018527413A (ja) | 2018-09-20 |
| US20220125929A1 (en) | 2022-04-28 |
| EP3357491A1 (en) | 2018-08-08 |
| HK1251464A1 (zh) | 2019-02-01 |
| KR101828877B1 (ko) | 2018-02-14 |
| RU2018113459A (ru) | 2019-10-18 |
| CN108024960B (zh) | 2020-12-29 |
| KR20170032858A (ko) | 2017-03-23 |
| CA2998092C (en) | 2020-08-04 |
| KR101948839B1 (ko) | 2019-02-15 |
| AU2016324450B2 (en) | 2019-04-18 |
| AU2016324450A1 (en) | 2018-04-12 |
| IL257937A (en) | 2018-05-31 |
| US11253598B2 (en) | 2022-02-22 |
| US20180250409A1 (en) | 2018-09-06 |
| EP3357491A4 (en) | 2019-05-08 |
| ZA201802303B (en) | 2019-01-30 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC43 | Official registration of the transfer of the exclusive right without contract for inventions |
Effective date: 20210811 |